Effect of Different Obesity Phenotypes on Cardiovascular Events in Tehran Lipid and Glucose Study (TLGS)

被引:62
作者
Hosseinpanah, Farhad [1 ]
Barzin, Maryam [1 ]
Sheikholeslami, Farhad [2 ]
Azizi, Fereidoun [2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Obes Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran
关键词
BODY-MASS INDEX; METABOLIC SYNDROME; NORMAL-WEIGHT; RISK-FACTORS; CARDIOMETABOLIC RISK; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; JAPANESE MEN; DISEASE RISK; VISCERAL FAT;
D O I
10.1016/j.amjcard.2010.09.034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this community-based study, 6,215 subjects aged >= 30 years (43% men, mean age 47 years) free of cardiovascular disease (CVD) at baseline were followed for a mean of 8.1 years to assess risk for CVD stratified by body mass index and dysmetabolic status. Participants were stratified by body mass index categories (18.5 to 24.9 kg/m(2) = normal, 25 to 29.9 kg/m(2) = overweight, and >= 30 kg/m(2) = obese) and dysmetabolic status. Dysmetabolic status was defined as having metabolic syndrome according to the International Diabetes Federation's definition or diabetes. First CVD events occurred in 446 subjects. Multivariate-adjusted hazard ratios for CVD events in normal-weight, overweight, and obese subjects without dysmetabolic status were 1.00 (reference), 1.10 (95% confidence interval [CI] 0.76 to 1.61), and 1.07 (95% CI 0.59 to 1.96), respectively, and for normal-weight, overweight and obese subjects with dysmetabolic status were 2.10 (95% CI 1.36 to 3.26), 2.35 (95% CI 1.71 to 3.22), and 2.35 (95% CI 1.71 to 3.22), respectively. There was an interaction between body mass index and metabolic abnormalities in predicting CVD. In conclusion, normal-weight subjects with dysmetabolic status had higher risk for future CVD compared to healthy obese subjects. (C) 2011 Elsevier Inc. All rights reserved. (Am J Cardiol 2011;107:412-416)
引用
收藏
页码:412 / 416
页数:5
相关论文
共 29 条
[1]   COMPENDIUM OF PHYSICAL ACTIVITIES - CLASSIFICATION OF ENERGY COSTS OF HUMAN PHYSICAL ACTIVITIES [J].
AINSWORTH, BE ;
HASKELL, WL ;
LEON, AS ;
JACOBS, DR ;
MONTOYE, HJ ;
SALLIS, JF ;
PAFFENBARGER, RS .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1993, 25 (01) :71-80
[2]   Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (Phase 1) [J].
Azizi, F ;
Rahmani, M ;
Emami, H ;
Mirmiran, P ;
Hajipour, R ;
Madjid, M ;
Ghanbili, J ;
Ghanbarian, A ;
Mehrabi, Y ;
Saadat, N ;
Salehi, R ;
Mortazavi, N ;
Heydarian, P ;
Sarbazi, N ;
Allahverdian, S ;
Saadati, N ;
Ainy, E ;
Moeini, S .
SOZIAL-UND PRAVENTIVMEDIZIN, 2002, 47 (06) :408-426
[3]   Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II [J].
Azizi, Fereidoun ;
Ghanbarian, Arash ;
Momenan, Amir Abbas ;
Hadaegh, Farzad ;
Mirmiran, Parvin ;
Hedayati, Mehdi ;
Mehrabi, Yadollah ;
Zahedi-Asl, Saleh .
TRIALS, 2009, 10
[4]   Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies [J].
Barba, C ;
Cavalli-Sforza, T ;
Cutter, J ;
Darnton-Hill, I ;
Deurenberg, P ;
Deurenberg-Yap, M ;
Gill, T ;
James, P ;
Ko, G ;
Miu, AH ;
Kosulwat, V ;
Kumanyika, S ;
Kurpad, A ;
Mascie-Taylor, N ;
Moon, HK ;
Nishida, C ;
Noor, MI ;
Reddy, KS ;
Rush, E ;
Schultz, JT ;
Seidell, J ;
Stevens, J ;
Swinburn, B ;
Tan, K ;
Weisell, R ;
Wu, ZS ;
Yajnik, CS ;
Yoshiike, N ;
Zimmet, P .
LANCET, 2004, 363 (9403) :157-163
[5]   Body-mass index and mortality in a prospective cohort of US adults [J].
Calle, EE ;
Thun, MJ ;
Petrelli, JM ;
Rodriguez, C ;
Heath, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) :1097-1105
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle East The National Survey of Risk Factors for Noncommunicable Diseases of Iran [J].
Delavari, Alireza ;
Forouzanfar, Mohammad Hossein ;
Alikhani, Siamak ;
Sharifian, Afsaneh ;
Kelishadi, Roya .
DIABETES CARE, 2009, 32 (06) :1092-1097
[8]   Metabolic syndrome in normal-weight Iranian adults [J].
Hadaegh, Farzad ;
Zabetian, Azadeh ;
Harati, Hadi ;
Azizi, Fereidoun .
ANNALS OF SAUDI MEDICINE, 2007, 27 (01) :18-24
[9]   Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study [J].
Hadaegh, Farzad ;
Harati, Hadi ;
Ghanbarian, Arash ;
Azizi, Fereidoun .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2006, 13 (04) :571-577
[10]   Associations Between Metabolic Syndrome and Mortality From Cardiovascular Disease in Japanese General Population, Findings on Overweight and Non-Overweight Individuals - Ibaraki Prefectural Health Study [J].
Irie, Fujiko ;
Iso, Hiroyasu ;
Noda, Hiroyuki ;
Sairenchi, Toshimi ;
Otaka, Erniko ;
Yamagishi, Kazumasa ;
Doi, Mikio ;
Izumi, Yoko ;
Ota, Hitoshi .
CIRCULATION JOURNAL, 2009, 73 (09) :1635-1642